Sorafenib-Inhibited Signaling: Emerging Evidence of RAFIndependent Pathways as Potential Therapeutic Targets in Hepatocellular Carcinoma

doi 10.5772/55201
Full Text
Abstract

Available in full text

Date
Authors
Publisher

InTech

Related search

Signaling Pathways in Schizophrenia: Emerging Targets and Therapeutic Strategies

Trends in Pharmacological Sciences
ToxicologyPharmacology
2010English

Dickkopf-1 and Amphiregulin as Novel Biomarkers and Potential Therapeutic Targets in Hepatocellular Carcinoma

International Journal of Hematology-Oncology and Stem Cell Research
OncologyTransplantationHematology
2019English

Potential Signaling Pathways as Therapeutic Targets for Overcoming Chemoresistance in Mucinous Ovarian Cancer (Review)

Biomedical Reports
GeneticsPharmacologyMolecular BiologyBiochemistryNeuroscienceMedicineToxicologyPharmaceutics
2018English

Sorafenib in Hepatocellular Carcinoma

Clinical Medicine. Therapeutics
2009English

Quantitative Phosphoproteomic Analysis Identifies the Potential Therapeutic Target EphA2 for Overcoming Sorafenib Resistance in Hepatocellular Carcinoma Cells

Experimental and Molecular Medicine
BiochemistryMedicineClinical BiochemistryMolecular BiologyMolecular Medicine
2020English

Therapeutic Targets in the ASK1-dependent Stress Signaling Pathways

Proceedings of the Japan Academy Series B: Physical and Biological Sciences
MultidisciplinaryBiological SciencesMedicineAgriculturalAstronomyPhysics
2012English

Signaling Pathways Involved in Molecular Carcinogenesis of Hepatocellular Carcinoma

2012English

Emerging Role of Hpo Signaling and YAP in Hepatocellular Carcinoma

Journal of Hepatocellular Carcinoma
2015English

GPCRs as Potential Therapeutic Targets in Preeclampsia

Drug Discovery Today: Disease Models
Drug DiscoveryMolecular Medicine
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy